Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2014
04/17/2014US20140105923 Tumor antigen proteins or genes of polo-like kinase 1
04/17/2014US20140105919 Synergistic inhibition of erbb2/erbb3 signal pathways in the treatment of cancer
04/17/2014US20140105914 Humanised anti ctla-4 antibodies
04/17/2014US20140105912 Vista modulators for diagnosis and treatment of cancer
04/17/2014US20140105911 Method Of Treatment Of Vascular Complications
04/17/2014US20140105908 Methods for treating prostate cancer
04/17/2014US20140105900 Methods and compositions relating to anti-il-21 receptor antibodies
04/17/2014US20140105898 Apoptosis-inducing molecules and uses therefor
04/17/2014US20140105897 Novel Anti-IL13 Antibodies and Uses Thereof
04/17/2014US20140105895 Treatment of solid tumors with rapamycin derivatives
04/17/2014US20140105893 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor
04/17/2014US20140105892 High concentration antibody and protein formulations
04/17/2014US20140105891 Treatment of cancer
04/17/2014US20140105887 Methods for modulating il-33 activity
04/17/2014US20140105885 Method for Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens
04/17/2014US20140105860 Engineered antibody-tnfsf member ligand fusion molecules
04/17/2014US20140105854 Vaccine for treatment and prevention of herpes simplex virus infection
04/17/2014US20140105853 Prostate cancer vaccine
04/16/2014EP2719704A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
04/16/2014EP2719397A1 Use of alpha-toxin for treating and preventing staphylococcus infections
04/16/2014EP2719396A1 Immunotherapy targeting intracellular pathogens
04/16/2014EP2719395A1 Adsorption of immunopotentiators to insoluble metal salts
04/16/2014EP2719394A1 Peptides antibodies directed thereagainst for diagnosing and treating amyloid-associated diseases
04/16/2014EP2718457A1 Engineered antibody-tnfsf member ligand fusion molecules
04/16/2014EP2718435A1 Sema5b peptides and vaccines including the same
04/16/2014EP2718429A1 Infectious clones of torque teno virus
04/16/2014EP2718428A1 Rabies virus like particle production in plants
04/16/2014EP2718427A1 Compositions and methods for glioblastoma treatment
04/16/2014EP2718326A1 Antibodies against g-csfr and uses thereof
04/16/2014EP2718322A1 Therapeutic antibodies
04/16/2014EP2718321A1 Anti-ricin antibodies and uses thereof
04/16/2014EP2717922A2 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
04/16/2014EP2717914A2 Sustained release formulations for delivery of proteins to the eye and methods of preparing same
04/16/2014EP2717913A2 Monoclonal antibody and antigens for diagnosing and treating lung disease and injury
04/16/2014EP2717912A1 Anti-cd22 antigen binding molecules to treat lung cancer and prostate cancer
04/16/2014EP2717911A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer
04/16/2014EP2717910A1 Peptide carrier fusion proteins as allergy vaccines
04/16/2014EP2717909A1 Compositions and methods related to p6 of haemophilus influenzae
04/16/2014EP2717908A1 Cetp fragments
04/16/2014EP2717901A2 He4 based therapy for malignant disease
04/16/2014CN103732750A Immunogenic composition
04/16/2014CN103732624A Anti-angptl3 antibodies and uses thereof
04/16/2014CN103732253A Use of small molecules in methods for purification of biomolecules
04/16/2014CN103732252A Combination therapy with an anti - CD19 antibody and a nitrogen mustard
04/16/2014CN103732251A Methods of treating systemic lupus erythematosus, scleroderma, and myositis with an antibody against interferon-alpha
04/16/2014CN103732250A Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
04/16/2014CN103732249A Influenza vaccines containing modified adenovirus vectors
04/16/2014CN103732248A Pharmaceutical compositions for preventing and/or treating an hiv disease in humans
04/16/2014CN103732247A Methods for handling biological drugs containing living cells
04/16/2014CN103732246A Method for preparing multiple antigen glycopeptide carbohydrate conjugates
04/16/2014CN103732222A Modified biotin-binding protein, fusion proteins thereof and applications
04/16/2014CN103725651A Porcine epidemic diarrhea virus stain and application thereof
04/16/2014CN103724433A Humanized anti-factor d antibodies and uses thereof
04/16/2014CN103724432A Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 )
04/16/2014CN103724431A Humanized anti-CD26 antibody and application thereof
04/16/2014CN103724430A Anti mif antibodies
04/16/2014CN103724429A Preparation method of anti-piglet diarrhea IgY (immunoglobulin of yolk)
04/16/2014CN103724413A B cell epitope 8A1 of trichina paramyosin and application thereof
04/16/2014CN103724409A Trichosanthin effective epitope peptide fragment with immunosuppression effect and application thereof
04/16/2014CN103724406A MERS-CoV (Middle East respiratory syndrome coronavirus) synthetic peptide vaccine with neutralization activity and application of MERS-CoV synthetic peptide vaccine
04/16/2014CN103724405A Type A foot-and-mouth disease CTL (cytotoxic T lymphocyte) epitope peptide and screening method thereof
04/16/2014CN103724404A Diastereomer polypeptide for inhibiting fusion of HIV (Human Immunodeficiency Virus) and host cells and application of diastereomer polypeptide
04/16/2014CN103724402A Complement function related antigen epitope and antibody of trichina paramyosin
04/16/2014CN103721255A Application of co-blocking of PD-1 and TIM-3 signal paths to anti-stomach-cancer treatment
04/16/2014CN103721254A Method for preparing swine A-type clostridium perfringens aluminum hydroxide inactivated vaccine
04/16/2014CN103721253A Live avian encephalomylitis and henpox combined vaccine
04/16/2014CN103721252A Gelatin-free rubella vaccine freeze-dried formula and process
04/16/2014CN103721251A Purification method for split influenza virus vaccine
04/16/2014CN103721250A Attenuated pestivirus
04/16/2014CN103721249A Meningitis vaccine and preparation method thereof
04/16/2014CN103720719A Technology for treating lupus erythematosus by DC (dendritic cell) and Treg (T regulator cell)
04/16/2014CN103275222B Monoclonal antibody for blocking 12p40 function of interleukin as well as coding gene and application thereof
04/16/2014CN103204908B MTA1-derived anti-tumour CTL (cytotoxiclymphocyte) epitope peptide and application thereof
04/16/2014CN103191422B Triple oral vaccine for cultivating marine fishes as well as preparation method and use method thereof
04/16/2014CN103130873B Antituberculous CTL (Cytotoxic T Lymphocyte) epitope peptide with drug-resistant related efflux protein source for tuberculosis and application of epitope peptide
04/16/2014CN102924576B Helicobacter pylori immunodominance epitope peptide and preparation method and application thereof
04/16/2014CN102908625B Chicken Newcastle disease and avian infectious bronchitis bivalent live vaccine heat-resistant protective agent and preparation process thereof
04/16/2014CN102813921B Novel compound aluminum hydroxide adjuvant for foot-and-mouth disease vaccine and vaccine preparation method
04/16/2014CN102764435B Porcine Asian type-I foot-and-mouth disease virus inactivated vaccine adjuvant and preparation method thereof
04/16/2014CN102757484B HCV (hepatitis C virus) poly-epitope peptide vaccine and application thereof
04/16/2014CN102746414B Sedimentation method of lipopolysaccharides
04/16/2014CN102660551B VHH (variable domain of heavy chain of heavy-chain antibody) antibody gene derived from anti-CyPA (CyclophilinA) animal of family Camelidae, encoded polypeptide, and application thereof
04/16/2014CN102618557B Recombinant avian flavivirus E protein and application thereof
04/16/2014CN102481371B Sticky soft gel for treating poultry
04/16/2014CN102227442B Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
04/16/2014CN102112153B Use of inactivated japanese encephalitis virus particle as adjuvant
04/16/2014CN102089324B Compositions and methods for the therapy and diagnosis of influenza
04/16/2014CN101952426B Anti-BST2 antibody
04/16/2014CN101909648B Compositions and methods for treating inflammation
04/16/2014CN101687039B Engineered anti-alpha v- integrin hybrid antibodies
04/15/2014US8697848 Method for reducing immunogenicity of therapeutic protein compositions
04/15/2014US8697845 Antibodies specifically directed to a soluble form of CTLA-4
04/15/2014US8697836 Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response
04/15/2014US8697628 Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes
04/15/2014US8697353 Immunization compositions and methods
04/15/2014US8697137 Methods of using microspheres for active embolization
04/15/2014US8697104 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
04/15/2014US8697092 Identification of a conserved inner core oligosaccharide of Moraxella catarrhalis lipopolysaccharide as a vaccine antigen
04/15/2014US8697091 Mycobacterium antigens
04/15/2014US8697090 Method of treating persistent genital arousal disorder with a neurotoxin
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 1823